CD80 (B7-1) and CD86 (B7-2): Potential targets for immunotherapy?
- 30 April 1995
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 146 (3) , 183-196
- https://doi.org/10.1016/0923-2494(96)80256-2
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from human immunodeficiency virus‐infected individualsEuropean Journal of Immunology, 1995
- Elevated expression of cd80 (b7/bb1) and other accessory molecules on synovial fluid mononuclear cell subsets in rheumatoid arthritisArthritis & Rheumatism, 1994
- Immunological functions of non-professional antigen-presenting cells: new insights from studies of T-cell interactions with keratinocytesImmunology Today, 1994
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- T cell co-stimulation and in vivo toleranceCurrent Opinion in Immunology, 1993
- Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantationImmunology Today, 1993
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals.The Journal of Experimental Medicine, 1992